Insights

Biotech Focus Emerging biotech research startup focusing on genetic medicines and biomolecular learning, signaling potential need for advanced data infrastructure, computational tools, and collaboration platforms to accelerate R&D.

Small Team, High Potential Limited headcount (2-10 employees) suggests frequent need for scalable outsourcing, contract research, and specialist services in genomics, protein engineering, and data processing to support rapid development.

Cloud & Collaboration Active use of Google Cloud and Google Workspace indicates openness to cloud-based bioinformatics pipelines, secure collaboration, and potential for cloud tenancy, big-data workflows, and DevOps alignment.

Non-Revenue Stage Revenue is currently zero to one million, implying an early-stage company with budget constraints but strong growth trajectory; opportunity to offer grant-funded programs, pilot contracts, and phased engagements.

Strategic Partnerships Interest in novel protein modalities and therapeutic optimization suggests value in partnering with contract research organizations, specialty CROs, and equipment or software providers to accelerate discovery and preclinical work.

Similar companies to March Therapeutics

March Therapeutics Tech Stack

March Therapeutics uses 8 technology products and services including LiteSpeed Cache, Wix, MySQL, and more. Explore March Therapeutics's tech stack below.

  • LiteSpeed Cache
    Caching
  • Wix
    Content Management System
  • MySQL
    Database
  • Google Workspace
    Email
  • Google Cloud
    Infrastructure As A Service
  • PWA
    Miscellaneous
  • reCAPTCHA
    Security
  • LiteSpeed
    Web Servers

Media & News

March Therapeutics's Email Address Formats

March Therapeutics uses at least 1 format(s):
March Therapeutics Email FormatsExamplePercentage
First@marchtx.comJohn@marchtx.com
100%

Frequently Asked Questions

What is March Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
March Therapeutics's official website is marchtx.com and has social profiles on LinkedIn.

What is March Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
March Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does March Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, March Therapeutics has approximately 3 employees across 1 continents, including North America. Key team members include Founder And Cto: F. F.Scientific Director, Discovery: N. G.. Explore March Therapeutics's employee directory with LeadIQ.

What industry does March Therapeutics belong to?

Minus sign iconPlus sign icon
March Therapeutics operates in the Biotechnology Research industry.

What technology does March Therapeutics use?

Minus sign iconPlus sign icon
March Therapeutics's tech stack includes LiteSpeed CacheWixMySQLGoogle WorkspaceGoogle CloudPWAreCAPTCHALiteSpeed.

What is March Therapeutics's email format?

Minus sign iconPlus sign icon
March Therapeutics's email format typically follows the pattern of First@marchtx.com. Find more March Therapeutics email formats with LeadIQ.

How much funding has March Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, March Therapeutics has raised $2.7M in funding. The last funding round occurred on Apr 01, 2020.

When was March Therapeutics founded?

Minus sign iconPlus sign icon
March Therapeutics was founded in 2020.
March Therapeutics logo

March Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

March Therapeutics is a biotechnology research company focused on advancing genetic medicines. Its work centers on applying an evolutionary approach that combines molecular recording and advanced computing to identify and optimize novel protein modalities for therapeutic use, aiming to enhance the discovery and development process. The company serves researchers and developers in the biopharma space seeking innovative genetic medicine solutions, addressing challenges in discovering durable and effective protein-based therapies. Based in Cambridge, Massachusetts, the firm operates within the biotechnology research sector and emphasizes scientifically driven methods to mine natural diversity for therapeutic applications. The organization is small in size, reflecting its early-stage footprint in this specialized field, and recent developments include ongoing explorations into its Biomolecular Learning framework as a core avenue for its research activities.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $2.7M

    March Therapeutics has raised a total of $2.7M of funding over 1 rounds. Their latest funding round was raised on Apr 01, 2020as a series_unknown.

  • $1M

    March Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $2.7M

    March Therapeutics has raised a total of $2.7M of funding over 1 rounds. Their latest funding round was raised on Apr 01, 2020as a series_unknown.

  • $1M

    March Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.